Original Research
Published on 24 Jun 2021
Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
in Cancer Molecular Targets and Therapeutics
- 6,918 views
- 18 citations





